Beam TherapeuticsInc Stock Performance

BEAM
 Stock
  

USD 44.69  0.59  1.34%   

The firm shows a Beta (market volatility) of 2.0189, which signifies a somewhat significant risk relative to the market. Let's try to break down what Beam TherapeuticsInc's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Beam TherapeuticsInc will likely underperform. Even though it is essential to pay attention to Beam TherapeuticsInc historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Beam TherapeuticsInc exposes twenty-one different technical indicators, which can help you to evaluate its performance. Beam TherapeuticsInc has an expected return of -0.28%. Please be advised to confirm Beam TherapeuticsInc jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Beam TherapeuticsInc performance from the past will be repeated at some point in the near future.
  
Beam TherapeuticsInc Performance
0 of 100
Over the last 90 days Beam TherapeuticsInc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively steady which may send shares a bit higher in January 2023. The new chaos may also be a sign of medium-term up-swing for the company stakeholders. ...more

Beam TherapeuticsInc Price Channel

Begin Period Cash Flow177011000.00
Total Cashflows From Investing Activities-294144000.00

Beam TherapeuticsInc Relative Risk vs. Return Landscape

If you would invest  5,758  in Beam TherapeuticsInc on September 10, 2022 and sell it today you would lose (1,289)  from holding Beam TherapeuticsInc or give up 22.39% of portfolio value over 90 days. Beam TherapeuticsInc is currently does not generate positive expected returns and assumes 5.0926% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Beam TherapeuticsInc, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Beam TherapeuticsInc is expected to under-perform the market. In addition to that, the company is 3.39 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.01 per unit of volatility.

Beam TherapeuticsInc Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Beam TherapeuticsInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beam TherapeuticsInc, and traders can use it to determine the average amount a Beam TherapeuticsInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0543

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsBEAM
Estimated Market Risk
 5.09
  actual daily
 
 44 %
of total potential
 
4444
Expected Return
 -0.28
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.05
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Beam TherapeuticsInc is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beam TherapeuticsInc by adding it to a well-diversified portfolio.

About Beam TherapeuticsInc Performance

To evaluate Beam TherapeuticsInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Beam TherapeuticsInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Beam TherapeuticsInc Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Beam TherapeuticsInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Beam TherapeuticsInc's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(72.34) (78.05) 
Return on Average Assets(38.49) (41.52) 
Return on Average Equity(69.13) (74.59) 
Return on Invested Capital(0.55) (0.59) 
Return on Sales(7.15) (7.72) 

Things to note about Beam TherapeuticsInc

Checking the ongoing alerts about Beam TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beam TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Beam TherapeuticsInc Alerts

Equity Alerts and Improvement Suggestions

Beam TherapeuticsInc generated a negative expected return over the last 90 days
Beam TherapeuticsInc has high historical volatility and very poor performance
The company reported the previous year's revenue of 51.84 M. Net Loss for the year was (370.64 M) with loss before overhead, payroll, taxes, and interest of (180.29 M).
Beam TherapeuticsInc currently holds about 1.09 B in cash with (66.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.9.
Beam TherapeuticsInc has a poor financial position based on the latest SEC disclosures
Over 87.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzingas Most Accurate Analysts By Benzinga - Investing.com UK
Continue to Trending Equities. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Beam TherapeuticsInc Stock analysis

When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam TherapeuticsInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.1 B
Quarterly Revenue Growth YOY
19.706
Return On Assets
(0.08) 
Return On Equity
(0.40) 
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam TherapeuticsInc that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Beam TherapeuticsInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.